On October 1, 2025, Haleon plc purchased 1,561,229 shares at an average price of £335.07 as part of its buyback program initiated on July 31, 2025. Since the beginning of 2025, the company has repurchased a total of 175,806,525 shares, including shares acquired from Pfizer.